Minimally invasive esophagectomy for Barrett's with high-grade dysplasia and early adenocarcinoma of the esophagus

Journal of Gastrointestinal Surgery

Volumn 14, Issue 6, 2010, Pages 948-950

  Pennathur, Arjun ^a   Awais, Omar ^a   Luketich, James D ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; ESOPHAGUS; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; HUMAN; MINIMALLY INVASIVE SURGERY; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; QUALITY OF LIFE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGUS; HUMANS; PROGNOSIS; QUALITY OF LIFE; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 77952544493     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-1152-8     Document Type: Article

References (16)

1. Erzinger PC, Mayer RJ et al. Esophageal Cancer. N Engl J Med 2004; 349: 2241-2252.
2. Pennathur A, Landreneau RJ, Luketich JD. Surgical aspects of the patient with high-grade dysplasia. Semin Thorac Cardiovasc Surg 2005; 17(4): 326-332.
3. Pennathur A, Farkas A, Krasinskas AM, Ferson PF, Gooding WE, Gibson MK, Schuchert MJ, Landreneau RJ, Luketich JD. Esophagectomy for T1 esophageal cancer: Outcomes in 100 patients and Implications for Endoscopic therapy. Ann Thorac Surg 2009; 87(4): 1048-1055.
4. Korst RJ, Altorki NK. High grade dysplasia: Surveillance, mucosal ablation, or resection? World J Surg 2003; 27: 1030-1034.
5. Hameeteman W, Tytgat GNJ, Houthoff HJ et al. Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96: 1249-56.
6. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identity low- and high- risk patient subsets. Am J Gastroenterol 2000; 95(7): 1669-1676.
7. Schnell TG, Sontag SJ, Chejfec G et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120: 1607-19.
8. Cameron AJ, Carpenter HA. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 1997; 92: 586-591.
9. Spechler SJ. Dysplasia in Barretts esophagus. Limitations of current management strategies. Am J Gastroenterol 2005; 100: 927-935.
10. Ormsby AH, Petras RE, Henricks WH et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 2002; 51: 67-16.
11. Pelligrini CA, Pohl D. High-Grade dysplasia in Barrett's esophagus: Surveillance or operation? J Gastointest Surg 2000; 4: 131-134.
12. Collard J. High grade dysplasia in Barrett's esophagus. The case for esophagectomy. Chest Surg Clinics North America 12; 1: 77-92.
13. Birkmeyer JD, Siewers AE, Finlayson EVA et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-37.
14. Luketich JD, Alvelo-Rivera M, Buenaventura PO et al. Minimally Invasive Esophagectomy. Outcomes in 222 patients. Annals Surg 2003; 238(4): 486-495.
15. Headrick JR, Nichols FC III, Miller DL et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 2002; 73: 1697-1703.
16. Peters JH. The management of dysplastic Barrett's esophagus: Where do we go from here? Ann Surg Oncol 2002; 9: 215-216.